Why the study?
Does increasing severity of obesity increase the prevalence of the metabolic syndrome and adverse cardiovascular biomarkers in children and adolescents?
Population
490 children and adolescents (439 obese, 31 overweight, 20 nonobese) from a multiethnic, multiracial cohort
Comparison
Varying degrees of obesity (exposure) vs Nonobese children and adolescents (n=20)
Design
Cross-sectional
Authors
Loading...
Supports monitoring for metabolic syndrome as obesity severity rises in youth; leaves open optimal intervention thresholds.
Does increasing severity of obesity increase the prevalence of the metabolic syndrome and adverse cardiovascular biomarkers in children and adolescents?
The prevalence of metabolic syndrome and adverse cardiovascular biomarkers is high and increases with worsening obesity in children and adolescents.
Weiss et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: